American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 283.e1-283.e8 , March 2008

Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial

  • Leila Katz, MD, PhD

      Affiliations

    • Departments of Obstetrics and Gynecology, Professor Fernando Figueira Institute for Maternal and Child Health Care, Recife, Pernambuco, Brazil
    • Corresponding Author InformationReprints: Dr. Leila Katz, Departments of Obstetrics and Gynecology, Professor Fernando Figueiroa Institute for Maternal and Child Health Care, Recife, Pernambuco, Rua Frei Matias Teves, No. 280, sala 418, Ilha do Leite, Recife-PE, Brazil.
    • ,
  • Melania Maria Ramos de Amorim, MD, PhD

      Affiliations

    • Departments of Obstetrics and Gynecology, Professor Fernando Figueira Institute for Maternal and Child Health Care, Recife, Pernambuco, Brazil
    • University of Campina Grande School of Medicine, Campina Grande, Paraíba, Brazil
    • ,
  • José Natal Figueiroa, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Professor Fernando Figueira Institute for Maternal and Child Health Care, Recife, Pernambuco, Brazil
    • ,
  • João Luiz Pinto e Silva, MD, PhD

      Affiliations

    • Universidade Estadual de Campinas School of Medicine, Campinas, São Paulo, Brazil.

Received 5 June 2007 ,Revised 17 August 2007 ,Accepted 11 October 2007.

References 

  1. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol. 1990;162:311–316
  2. Maggann EF, Martin JN. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol. 1999;42:532–550
  3. Santos LC, Amorim MMR, Katz L, Albuquerque CJM. Terapia Intensiva em Obstetrícia, Rio de Janeiro: Medsi; 2004. Capítulo 5:63-75.
  4. Thiagarajah S, Bourgeois FJ, Harbert GM, Caudle MR. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol. 1984;150:1–7
  5. Yalcin OT, Sener T, Hassa H, Ozalp S, Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynecol Obstet. 1998;61:141–148
  6. Suresh MS. HELLP syndrome: an anesthesiologist’s perspective. Anesth Clin North Am. 1998;16:332–348
  7. O’Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroids therapy in patients with HELLP (hemolysis, elevated liver enzymes and low platelets count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol. 2002;186:475–479
  8. Mecacci F, Carignani L, Cioni R, et al. Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone. Thromb Res. 2001;102:99–105
  9. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal-morbidity and mortality in 442 pregnacies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000–1006
  10. Martin JN, Files JC, Blake PG, et al. Plasma exchange for preeclampsia (I. Postpartum use for persistent severe preeclampsia-eclampsia with HELLP syndrome). Am J Obstet Gynecol. 1990;162:128–137
  11. Martin JN, Files JC, Blake PG, Perry KG, Morrison JC, Norman PH. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1995;172:1107–1127
  12. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol. 1994;171:1148–1153
  13. Vigil-De Gracia PE, García-Cáceres E. Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynecol Obstet. 1997;59:17–22
  14. Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193:1591–1598
  15. Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol. 1997;177:1011–1017
  16. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol. 1999;181:304–309
  17. Varol F, Aydin T, Gücer F. HELLP syndrome and postpartum corticosteroids. Int Gynaecol Obstet. 2001;73:157–159
  18. Isler CM, Barrillleaux PS, Magann EF, Bass JD, Martin JN. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Am J Obstet Gynecol. 2001;184:1332–1339
  19. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy (Cochrane Review). The Cochrane Library, Issue 4. Oxford: Update Software; 2004;
  20. Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol. 1966;9:954–972
  21. Bouchnak M, Souissi K, Ouragini H, Abbes Z, Douiri H, Maghrebi H. Intérêt de la corticothérapie en post partum dans le HELLP (hemolysis elevated liver enzymes low platelets count) syndrome. Tunis Med. 2005;83:473–476
  22. Roberts WE, Perry KG, Woods JB, Files JC, Blake PG, Martin JN. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications?. Am J Obstet Gynecol. 1994;171:799–804
  23. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai B. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks’ gestation. Am J Obstet Gynecol. 2000;183:1475–1479
  24. Nunes F, Campos AP, Avillez T, Rodrigues R, Meirinho M. Corticosteroid therapy for patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Acta Med Port. 2005;18:177–182
  25. van Runnard Heimel PJ, Huisjes AJ, Franx A, Koopman C, Bots ML, Bruinse HW. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol. 2006;128:187–193
  26. O’Brien . Dexamethasone, HELLP syndrome, and study design. Am J Obstet Gynecol. 2006;195:13–14
  27. Fonseca JE, Arias F, Mendez F. Dexamethasone, HELLP syndrome, and study design. Am J Obstet Gynecol. 2006;195:15–17
  28. Martin JN, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195:914–934
  29. Rychel V, Williams KP. Correlation of platelet count changes with liver cell destruction in HELLP syndrome. Hypertens Pregnancy. 2003;22:57–62

 Cite this article as: Katz L, de Amorim MMR, Figueiroa JN, et al. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2008;198:283.e1-283.e8.

PII: S0002-9378(07)02019-4

doi: 10.1016/j.ajog.2007.10.797

American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 283.e1-283.e8 , March 2008

Article Tools

* Image Usage & Resolution